InvestorsHub Logo
icon url

exwannabe

03/17/24 10:19 AM

#679185 RE: TTsr #679177

Why must Merck agree with a PR by NWBO from 2016 on a trial that never launched?

As the PR states, Merck would have supplied the Keytruda if the trial had been run. Yippeee.

The dot connect from the use of liquid biopsies show how totally clueless dstock, DD and others are on the actual subject.